[go: up one dir, main page]

ATE433991T1 - Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn - Google Patents

Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn

Info

Publication number
ATE433991T1
ATE433991T1 AT05737324T AT05737324T ATE433991T1 AT E433991 T1 ATE433991 T1 AT E433991T1 AT 05737324 T AT05737324 T AT 05737324T AT 05737324 T AT05737324 T AT 05737324T AT E433991 T1 ATE433991 T1 AT E433991T1
Authority
AT
Austria
Prior art keywords
crohn
disease
peptide
epitope peptide
reagent
Prior art date
Application number
AT05737324T
Other languages
English (en)
Inventor
Mikio Niwa
Katsuhiko Matsuo
Keiichi Mitsuyama
Michio Sata
Original Assignee
Toagosei Co Ltd
Univ Kurume
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toagosei Co Ltd, Univ Kurume filed Critical Toagosei Co Ltd
Application granted granted Critical
Publication of ATE433991T1 publication Critical patent/ATE433991T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05737324T 2004-08-05 2005-04-26 Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn ATE433991T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004229171 2004-08-05
PCT/JP2005/007857 WO2006013661A1 (ja) 2004-08-05 2005-04-26 クローン病抗体エピトープペプチド及びクローン病の検査試薬

Publications (1)

Publication Number Publication Date
ATE433991T1 true ATE433991T1 (de) 2009-07-15

Family

ID=35786960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05737324T ATE433991T1 (de) 2004-08-05 2005-04-26 Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn

Country Status (9)

Country Link
US (1) US7985831B2 (de)
EP (1) EP1780215B1 (de)
JP (1) JP4597132B2 (de)
KR (1) KR101159626B1 (de)
CN (2) CN101654474B (de)
AT (1) ATE433991T1 (de)
DE (1) DE602005014990D1 (de)
ES (1) ES2328261T3 (de)
WO (1) WO2006013661A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5660027B2 (ja) * 2009-03-05 2015-01-28 味の素株式会社 クローン病診断試薬
US20110177525A1 (en) * 2010-01-19 2011-07-21 Predictive Biosciences, Inc. Antibodies and methods of diagnosing diseases
WO2011130546A1 (en) * 2010-04-14 2011-10-20 Inova Diagnostics, Inc. Methods for differentiating between crohn's disease and other inflammatory bowel conditions
GB2506870B (en) * 2012-10-09 2014-11-12 Gos Networks Ltd Method for the reduction of signalling traffic on mobile devices
IT201600090052A1 (it) * 2016-09-06 2018-03-06 Univ Degli Studi Padova Peptide per la diagnosi differenziale della Malattia di Crohn
CN110256541A (zh) * 2019-05-15 2019-09-20 山西瑞豪生物科技有限公司 一种检测克隆恩氏病血清抗体的多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2001241408A1 (en) * 2000-01-31 2001-08-07 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2002088175A1 (fr) * 2001-04-24 2002-11-07 Otsuka Pharmaceutical Co., Ltd. Peptide de liaison a des anticorps de la maladie de crohn et methode d'examen de ladite maladie

Also Published As

Publication number Publication date
JP4597132B2 (ja) 2010-12-15
US7985831B2 (en) 2011-07-26
KR101159626B1 (ko) 2012-07-19
CN101654474B (zh) 2012-11-07
ES2328261T3 (es) 2009-11-11
EP1780215A1 (de) 2007-05-02
CN101654474A (zh) 2010-02-24
WO2006013661A1 (ja) 2006-02-09
KR20070037635A (ko) 2007-04-05
JPWO2006013661A1 (ja) 2008-05-01
US20090170115A1 (en) 2009-07-02
EP1780215A4 (de) 2007-11-14
DE602005014990D1 (de) 2009-07-30
EP1780215B1 (de) 2009-06-17
CN101031581A (zh) 2007-09-05

Similar Documents

Publication Publication Date Title
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
BRPI0519430A2 (pt) hormânio do crescimento humano modificado
WO2010065079A3 (en) Antibodies to il-6 and use thereof
GEP20105111B (en) Rage fusion proteins and methods of use
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
ATE485517T1 (de) Verfahren zur identifizierung von polypeptid- targets
EP1855719A4 (de) Neutralisierende monoklonale antikörper gegen coronaviren in zusammenhang mit schwerem akutem atemwegssyndrom
DE602004028513D1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
EA201100072A1 (ru) Новые композиции и способы
PL415888A1 (pl) Sposób wytwarzania insuliny i jej pochodnych oraz peptyd hybrydowy stosowany w tym sposobie
AR056125A1 (es) Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
ATE433991T1 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
DE502006006593D1 (de) Verfahren zum nachweis von autoimmunantikörpern gegen den tsh-rezeptor und neue tsh- rezeptorchimären
ATE530569T1 (de) Assays zum nachweis von tuberkulose- antigenen, und impfstoffe
JP2008537481A5 (de)
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
WO2004113386A3 (en) Modified hirudin proteins and t-cell epitopes in hirudin
HK1106001A1 (en) Method of screening for a carnitine transporter agonist or antagonist and its uses
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
ATE544856T1 (de) Peptid- und nukleotidsequenzen von anisakis spp. und ihre verwendung
ATE395356T1 (de) Oberflächenprotein aus neisserien
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species
WO2002075317A3 (en) Screening for drugs against disorders associated with schizophrenia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties